Old Web
English
Sign In
Acemap
>
authorDetail
>
L.C.S. De Vries
L.C.S. De Vries
Medicine
Cancer research
Janus kinase
Colitis
Inflammatory bowel disease
5
Papers
80
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (5)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Janus kinase inhibition in the treatment of inflammatory bowel disease
2020
L.C.S. De Vries
Show All
Source
Cite
Save
Citations (0)
A JAK1 Selective Kinase Inhibitor and Tofacitinib Affect Macrophage Activation and Function
2019
Inflammatory Bowel Diseases
L.C.S. De Vries
Jose Duarte
M de Krijger
Olaf Welting
P. van Hamersveld
F. W. van Leeuwen-Hilbers
Perry D. Moerland
Aldo Jongejan
Geert D’Haens
W. J. de Jonge
Manon E. Wildenberg
Show All
Source
Cite
Save
Citations (20)
DOP063 Inhibition of tyrosine kinase 2 signalling ameliorates T cell transfer colitis
2018
Journal of Crohns & Colitis
L.C.S. De Vries
Manon E. Wildenberg
Rose Willemze
H. P. van Hamersveld
Olaf Welting
Caroline Verseijden
Birgit Strobl
Mathias Mueller
G. DHaens
W. J. de Jonge
Show All
Source
Cite
Save
Citations (0)
The Future of Janus Kinase Inhibitors in Inflammatory Bowel Disease.
2017
Journal of Crohns & Colitis
L.C.S. De Vries
Manon E. Wildenberg
W.J. de Jonge
Geert D’Haens
Show All
Source
Cite
Save
Citations (60)
P007 Oral tyrosine kinase 2 inhibitor ameliorates T cell transfer colitis
2017
Journal of Crohns & Colitis
L.C.S. De Vries
Manon E. Wildenberg
P. van Hamersveld
Olaf Welting
Caroline Verseijden
G. DHaens
W. J. de Jonge
Show All
Source
Cite
Save
Citations (0)
1